• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白(a)基因多态性与汉族人钙化性主动脉瓣疾病和冠心病的相关性。

Correlations between lipoprotein(a) gene polymorphisms and calcific aortic valve disease and coronary heart disease in Han Chinese.

机构信息

Graduate School, Tianjin Medical University, Tianjin, China.

Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.

出版信息

J Int Med Res. 2020 Oct;48(10):300060520965353. doi: 10.1177/0300060520965353.

DOI:10.1177/0300060520965353
PMID:33100089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7645393/
Abstract

OBJECTIVE

To investigate the relationship between lipoprotein(a) gene () polymorphisms and calcific aortic valve disease (CAVD) and coronary heart disease (CHD) in Han Chinese.

METHODS

A total of 148 patients were recruited (n = 71 with CAVD and n = 77 with CHD) based on a diagnosis achieved using color Doppler echocardiography, coronary angiography, or computed tomography angiography. Seventy-one control individuals without CAVD or CHD were also recruited. Biomarkers including levels of lipoprotein(a) [Lp(a)], low-density lipoprotein and high-density lipoprotein cholesterol, apolipoprotein A1, and apolipoprotein B were tested. polymorphisms rs10455872, rs6415084, rs3798221, and rs7770628 were analyzed using SNaPshot SNP.

RESULTS

Lp(a) levels were significantly higher in CAVD and CHD groups compared with controls. There was no significant difference in the allelic frequency distribution of rs3798221, rs7770628, or rs6415084 between CHD, CAVD, and control groups. Linear regression showed that rs3798221, rs7770628, and rs6415084 were associated with increased Lp(a) concentrations. Two CAVD patients among the 219 participants carried AG minor alleles at rs10455872, while the remainder carried AA minor alleles.

CONCLUSION

rs3798221, rs6415084, and rs7770628 polymorphisms within are associated with higher Lp(a) plasma levels, which correlate with increased CAVD and CHD risks.

摘要

目的

探讨载脂蛋白(a)基因()多态性与汉族人群钙化性主动脉瓣疾病(CAVD)和冠心病(CHD)的关系。

方法

根据彩色多普勒超声心动图、冠状动脉造影或计算机断层血管造影检查的诊断,共纳入 148 例患者(n=71 例 CAVD 患者和 n=77 例 CHD 患者)。还纳入了 71 名无 CAVD 或 CHD 的对照组个体。检测了包括脂蛋白(a)[Lp(a)]、低密度脂蛋白和高密度脂蛋白胆固醇、载脂蛋白 A1 和载脂蛋白 B 在内的生物标志物。采用 SNaPshot SNP 分析 多态性 rs10455872、rs6415084、rs3798221 和 rs7770628。

结果

与对照组相比,CAVD 和 CHD 组的 Lp(a)水平明显升高。CHD、CAVD 和对照组之间 rs3798221、rs7770628 或 rs6415084 的等位基因频率分布无显著差异。线性回归显示 rs3798221、rs7770628 和 rs6415084 与 Lp(a)浓度升高相关。在 219 名参与者中,有 2 名 CAVD 患者携带 rs10455872 的 AG 小等位基因,其余患者携带 AA 小等位基因。

结论

内的 rs3798221、rs6415084 和 rs7770628 多态性与较高的 Lp(a)血浆水平相关,而 Lp(a)水平升高与 CAVD 和 CHD 风险增加相关。

相似文献

1
Correlations between lipoprotein(a) gene polymorphisms and calcific aortic valve disease and coronary heart disease in Han Chinese.载脂蛋白(a)基因多态性与汉族人钙化性主动脉瓣疾病和冠心病的相关性。
J Int Med Res. 2020 Oct;48(10):300060520965353. doi: 10.1177/0300060520965353.
2
Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.氧化磷脂与钙化性主动脉瓣疾病风险:哥本哈根普通人群研究
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1570-1578. doi: 10.1161/ATVBAHA.116.308761. Epub 2017 Jun 1.
3
Association between lipoprotein(a), LPA genetic risk score, aortic valve disease, and subsequent major adverse cardiovascular events.脂蛋白(a)、LPA 遗传风险评分与主动脉瓣疾病及随后主要不良心血管事件的相关性。
Eur J Prev Cardiol. 2024 Aug 9;31(10):1303-1311. doi: 10.1093/eurjpc/zwae100.
4
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
5
Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis.脂蛋白(a)电泳和免疫测定方法在鉴别钙化性主动脉瓣疾病和冠心病发病风险中的评估:动脉粥样硬化多族裔研究
Clin Chem. 2017 Nov;63(11):1705-1713. doi: 10.1373/clinchem.2016.270751. Epub 2017 Sep 13.
6
Pathobiology of Lp(a) in calcific aortic valve disease.脂蛋白(a)在钙化性主动脉瓣疾病中的病理生物学。
Expert Rev Cardiovasc Ther. 2017 Oct;15(10):797-807. doi: 10.1080/14779072.2017.1367286. Epub 2017 Aug 24.
7
Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.载脂蛋白(a)遗传变异与经皮冠状动脉介入治疗后的汉族冠心病患者后续心血管事件之间缺乏关联。
Lipids Health Dis. 2013 Aug 27;12:127. doi: 10.1186/1476-511X-12-127.
8
Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions.脂蛋白(a)与钙化性主动脉瓣疾病:当前的证据与未来方向。
Curr Opin Clin Nutr Metab Care. 2024 Jan 1;27(1):77-86. doi: 10.1097/MCO.0000000000000976. Epub 2023 Aug 28.
9
Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.脂蛋白相关磷脂酶 A2 在钙化性主动脉瓣疾病中的高表达:对瓣膜矿化的影响。
J Am Coll Cardiol. 2014 Feb 11;63(5):460-9. doi: 10.1016/j.jacc.2013.05.105. Epub 2013 Oct 23.
10
Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.脂蛋白(a)升高和 LPA 基因的遗传多态性可能预测心血管事件。
Sci Rep. 2022 Mar 4;12(1):3588. doi: 10.1038/s41598-022-07596-4.

引用本文的文献

1
Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants: A Critical Review From the Middle East.脂蛋白(a)及其基因变异对心血管的影响:来自中东的批判性综述
JACC Asia. 2025 Jul;5(7):847-864. doi: 10.1016/j.jacasi.2025.04.012.
2
Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease.血浆无细胞 DNA 是诊断钙化性主动脉瓣疾病的潜在生物标志物。
Cardiology. 2024;149(2):155-162. doi: 10.1159/000534229. Epub 2023 Oct 27.
3
Comprehensive Landscape of Modules-Dysregulated Functions Reveals a Profound Role of ceRNAs in Coronary Heart Disease.模块失调功能的综合全景揭示了 ceRNAs 在冠心病中的重要作用。
J Healthc Eng. 2022 Mar 8;2022:4547413. doi: 10.1155/2022/4547413. eCollection 2022.
4
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
5
Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement.中国人群中的脂蛋白(a)与心血管疾病:北京心脏学会专家科学声明
JACC Asia. 2022 Nov 15;2(6):653-665. doi: 10.1016/j.jacasi.2022.08.015. eCollection 2022 Nov.
6
Sex, age, and ethnic dependency of lipoprotein variants as the risk factors of ischemic heart disease: a detailed study on the different age-classes and genders in Tehran Cardiometabolic Genetic Study (TCGS).脂蛋白变异作为缺血性心脏病危险因素的性别、年龄和种族依赖性:德黑兰心脏代谢遗传研究(TCGS)中不同年龄和性别的详细研究。
Biol Sex Differ. 2022 Jan 28;13(1):4. doi: 10.1186/s13293-022-00413-7.
7
Impact of Fetuin-A, Lp(a), matrix gla protein and macrophage density on calcific aortic valve disease: a clinical study.成纤维细胞生长因子 23、脂蛋白(a)、基质 Gla 蛋白和巨噬细胞密度对钙化性主动脉瓣疾病的影响:一项临床研究。
Lipids Health Dis. 2022 Jan 22;21(1):14. doi: 10.1186/s12944-022-01625-x.
8
The effect of CYP7B1 polymorphisms on the risk of coronary heart disease in Hainan Han population.CYP7B1 多态性对海南汉族人群冠心病发病风险的影响。
BMC Med Genomics. 2021 Sep 7;14(1):220. doi: 10.1186/s12920-021-01067-x.

本文引用的文献

1
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.脂蛋白(a)浓度与心血管疾病和糖尿病风险。
J Am Coll Cardiol. 2019 Dec 17;74(24):2982-2994. doi: 10.1016/j.jacc.2019.10.019. Epub 2019 Dec 9.
2
Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype.他汀类药物治疗可增加低分子量载脂蛋白(a)表型患者的脂蛋白(a)水平。
Atherosclerosis. 2019 Oct;289:201-205. doi: 10.1016/j.atherosclerosis.2019.07.001. Epub 2019 Jul 3.
3
Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.LPA 基因多态性与行心脏手术的钙化性主动脉瓣狭窄患者及主动脉瓣微钙化的家族发病风险
JAMA Cardiol. 2019 Jul 1;4(7):620-627. doi: 10.1001/jamacardio.2019.1581.
4
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.脂蛋白(a)和氧化磷脂促进主动脉瓣狭窄患者的瓣膜钙化。
J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.
5
New Frontiers in Lp(a)-Targeted Therapies.新型靶向 Lp(a)治疗策略。
Trends Pharmacol Sci. 2019 Mar;40(3):212-225. doi: 10.1016/j.tips.2019.01.004. Epub 2019 Feb 4.
6
Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.伊朗冠心病患者中LPA序列变异rs6415084、rs3798220与传统冠状动脉疾病的相关性研究
Hum Antibodies. 2019;27(2):99-104. doi: 10.3233/HAB-180353.
7
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.深度覆盖全基因组序列和血浆脂蛋白(a)在欧洲和非洲血统个体。
Nat Commun. 2018 Jul 4;9(1):2606. doi: 10.1038/s41467-018-04668-w.
8
Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.脂蛋白(a)在临床实践中的应用:基础与转化科学的新视角。
Crit Rev Clin Lab Sci. 2018 Jan;55(1):33-54. doi: 10.1080/10408363.2017.1415866. Epub 2017 Dec 20.
9
Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.载脂蛋白 LPA 变异与主动脉瓣狭窄的相关性:基于电子健康记录中的诊断和操作代码的大规模研究。
JAMA Cardiol. 2018 Jan 1;3(1):18-23. doi: 10.1001/jamacardio.2017.4266.
10
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.脂蛋白(a)浓度、LPA 遗传变异与已确诊冠心病患者死亡风险的关系:一项分子遗传学关联研究。
Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.